Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer.
Pharmacoecon Open. 2022 Nov;6(6):899. doi: 10.1007/s41669-022-00372-0.
Pharmacoecon Open. 2022.
PMID: 36107308
Free PMC article.
No abstract available.
Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer.
Elsea D, Fan L, Mihai A, Moustaid FE, Simmons D, Monberg M, Muston D.
Elsea D, et al. Among authors: moustaid fe.
Pharmacoecon Open. 2022 Nov;6(6):811-822. doi: 10.1007/s41669-022-00338-2. Epub 2022 Aug 29.
Pharmacoecon Open. 2022.
PMID: 36036344
Free PMC article.
Item in Clipboard
The Role of Vector Trait Variation in Vector-Borne Disease Dynamics.
Cator LJ, Johnson LR, Mordecai EA, Moustaid FE, Smallwood TRC, LaDeau SL, Johansson MA, Hudson PJ, Boots M, Thomas MB, Power AG, Pawar S.
Cator LJ, et al. Among authors: moustaid fe.
Front Ecol Evol. 2020 Jul;8:189. doi: 10.3389/fevo.2020.00189. Epub 2020 Jul 10.
Front Ecol Evol. 2020.
PMID: 32775339
Free PMC article.
Item in Clipboard
Cite
Cite